Our team brings together healthcare and finance expertise

Medical specialist
Founder & Managing Partner
Fiona is an experienced doctor. Prior to investing in healthtech, she worked in the NHS in London as a radiologist at UCLH, one of the largest teaching hospitals in the UK. Fiona has developed national health policy at the UK Department of Health as clinical advisor to Professor Sir Bruce Keogh and also worked as a management consultant. She holds a stellar academic record with over 20 awards, bursaries and scholarships. Fiona holds an MBA from London Business School and an MPH from London School of Hygiene and Tropical Medicine. She is one of a select few doctors worldwide to be dual board certified in Radiology and Public Health.

Experienced investor
Partner
Søren is an experienced investor who has deep experience of asset allocation, investment strategy and macroeconomics. He has been CEO of IPQ Capital for the past six years where he manages all investments of the Family Office. IPQ Capital predominantly undertakes venture investments in the fintech space. Søren holds an MBA from London Business School and a Masters in Finance from Aarhus University, where he graduated in the top 1%. An experienced board director, Søren spent over five years on the executive board of Formuepleje, one of Scandinavia’s largest independent asset managers.
Our advisory board
Gianluca D’Avanzo
Gianluca has deep financial expertise with over 20 years’ experience in private equity, distressed investing and M&A.
Over the past decade, as co-founder and Managing Partner at Blue Skye Investment group, Gianluca has led numerous successful international special situations and private equity investments, with total investment in excess of $2Bn. He has helped to restructure and rebuild several large European companies. Gianluca is an experienced board director and currently sits on the board of AC Milan SpA, the football club.
Gianluca holds an executive MBA from London Business School and a B.A. in Finance from the Bocconi University in Milan, Italy, where he graduated magna cum laude.
Petar Jovanovic
Petar is a senior business executive with a proven history of success in delivering business results. He is a strong proponent of innovation and change.
Petar has been Deputy CEO of Raiffeisen Bank Belgrade for the last five years where he manages Retail Banking and Asset Management business. He is also Chairman of the Supervisory board of Raiffeisen Invest – Asset management company and Raiffeisen Future – Private Pension fund. Additionally, Petar is a member of the Digital Serbia Initiative’s Managing Board which is a non-profit, non-governmental organisation with the strategic goal of developing a strong, globally competitive digital economy in Serbia.
Petar has extensive international experience in multicultural environments both through his current function and through the regional Vice President role, being involved in Raiffeisen Bank International’s retail banking business in 15 CEE countries.
Petar holds an Executive MBA Degree from London Business School and a B.A. Degree from the Faculty of Economics, University of Belgrade, Serbia.
Sir Andrew Likierman
Andrew is a former Dean of the London Business School, where he continues to teach and to research on the use of judgement in management.
Andrew has started his own book business, run a textile plant in Germany and was Head of the UK Government Accountancy Service. Previous non-executive posts included Chairman of the National Audit Office, Economists’ Bookshop Group, market research firm MORI and US battery technology company AIC. He was non-executive Director of the Bank of England and Barclays Bank, and President of the Chartered Institute of Management Accountants. He is currently the Senior non-executive Director of Times Newspapers Holdings, director of the quoted Lloyds insurance underwriter Beazley plc and of Monument, a start-up bank.
Andrew advised the House of Commons Treasury Select Committee and was a member of several official inquiries, including the “Cadbury Committee” on UK corporate governance and of the UN Secretary-General’s committee on the governance of the United Nations.
Pam Garside
Pam Garside is a management consultant working in health care systems and digital health in the UK and internationally and an angel investor in early stage health tech companies.
She is a Fellow of the Judge Business School of the University of Cambridge and a member of the Investment Committee of Cambridge Enterprise, the technology transfer company of the University. Pam founded and co-chairs The Cambridge Health Network, a membership group of senior players in UK health, both private and public sector. She is a board member of Cambridge Angels, Crown Place VCT, several start-ups and Whizz-Kidz and Punchdrunk charities. Pam is advises a number of health technology accelerators in the UK.
Pam began her professional life in management in the NHS and subsequently spent many years studying and working internationally based in the USA. She holds a BSc from the University of Durham and a Masters Degree in Hospital and Health Care Administration from the University of Minnesota. She is an Adjunct Professor at Imperial College Business School.
Søren Fryland Møller
Søren is an experienced investor and board director who has deep experience of asset allocation, investment strategy and macroeconomics. He has been CEO of IPQ Capital for the past six years where he manages both the liquid and venture investments of the Family Office. IPQ Capital predominantly undertakes venture investments in the fintech space. Søren spent over five years on the executive board of Formuepleje, one of Scandinavia’s largest independent asset managers.
Dr Fiona Pathiraja
Fiona is an experienced doctor, who prior to investing in healthtech, spent most of her career in the NHS in London. She was a consultant radiologist at UCLH, one of the largest teaching hospitals in the UK. Fiona developed national health policy at the UK Department of Health and has also worked as a management consultant. She is board certified in Radiology and Public Health and is one of a very few doctors to hold both an MBA and MPH.